The Goldman Sachs Group Raises Xylem (NYSE:XYL) Price Target to $99.00

Xylem (NYSE:XYLGet Rating) had its target price hoisted by The Goldman Sachs Group from $87.00 to $99.00 in a report issued on Wednesday morning, Marketbeat.com reports. The Goldman Sachs Group currently has a neutral rating on the industrial products company’s stock.

Other research analysts have also issued reports about the company. Cowen upgraded Xylem from a market perform rating to an outperform rating in a research report on Wednesday, June 1st. Cowen raised Xylem from a market perform rating to an outperform rating and set a $75.00 price target for the company in a research report on Wednesday, June 1st. Northcoast Research began coverage on Xylem in a research report on Friday, July 15th. They set a neutral rating for the company. Mizuho reduced their price target on Xylem from $85.00 to $80.00 and set a neutral rating for the company in a research report on Monday, July 18th. Finally, Morgan Stanley reduced their price target on Xylem from $110.00 to $100.00 and set an overweight rating for the company in a research report on Thursday, June 9th. Ten investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Xylem has an average rating of Hold and a consensus price target of $102.30.

Xylem Stock Down 0.5 %

Shares of XYL opened at $97.22 on Wednesday. The firm has a market capitalization of $17.51 billion, a price-to-earnings ratio of 41.91, a PEG ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.21 and a current ratio of 1.63. The business’s fifty day moving average price is $81.89 and its two-hundred day moving average price is $86.08. Xylem has a 52 week low of $72.08 and a 52 week high of $138.78.

Xylem (NYSE:XYLGet Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The industrial products company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.12. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.33 billion. Xylem had a return on equity of 13.66% and a net margin of 8.06%. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.66 EPS. On average, analysts predict that Xylem will post 2.54 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 23rd. Investors of record on Thursday, May 26th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend was Wednesday, May 25th. Xylem’s dividend payout ratio (DPR) is presently 51.72%.

Insider Activity at Xylem

In related news, Director Jeanne Beliveau-Dunn sold 600 shares of the stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $96.65, for a total value of $57,990.00. Following the sale, the director now owns 7,553 shares in the company, valued at approximately $729,997.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Xylem news, SVP Hayati Yarkadas sold 5,898 shares of the stock in a transaction on Monday, June 27th. The stock was sold at an average price of $80.06, for a total transaction of $472,193.88. Following the transaction, the senior vice president now owns 9,556 shares in the company, valued at approximately $765,053.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeanne Beliveau-Dunn sold 600 shares of the stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $96.65, for a total value of $57,990.00. Following the transaction, the director now owns 7,553 shares in the company, valued at approximately $729,997.45. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,655 shares of company stock worth $691,104. Company insiders own 0.89% of the company’s stock.

Institutional Trading of Xylem

Several large investors have recently modified their holdings of XYL. James Reed Financial Services Inc. acquired a new stake in shares of Xylem during the 4th quarter worth $26,000. UMB Bank N A MO acquired a new stake in shares of Xylem during the 4th quarter worth $27,000. AGF Investments LLC acquired a new stake in shares of Xylem during the 4th quarter worth $27,000. Cassady Schiller Wealth Management LLC acquired a new stake in shares of Xylem during the 4th quarter worth $34,000. Finally, Riverview Trust Co acquired a new stake in shares of Xylem during the 1st quarter worth $26,000. 83.83% of the stock is owned by institutional investors and hedge funds.

Xylem Company Profile

(Get Rating)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Read More

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.